Burkholderia cepacia complex and cystic fibrosis: In search of the smoking gun

American Journal of Respiratory and Critical Care Medicine

Volumn 170, Issue 1, 2004, Pages 6-7

  Speert, David P ^a   Goldberg, Joanna B ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR; LIPOPOLYSACCHARIDE;

ANTIBIOTIC RESISTANCE; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DISEASE ASSOCIATION; EDITORIAL; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA COMPLEX; CLASSIFICATION; METABOLISM; MICROBIOLOGY; NOTE; PATHOPHYSIOLOGY; RESPIRATORY TRACT INFECTION; SEROTYPING;

BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; HUMANS; LIPOPOLYSACCHARIDES; RESPIRATORY TRACT INFECTIONS; SEROTYPING;

EID: 3242891430     PISSN: 00030805     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (11)

1. Speert DP. Advances in Burkholderia cepacia complex. Paediatr Respir Rev 2002;3:230-235.
2. De Soyza A, Ellis CD, Khan CM, Corris PA, Demarco de Hormaeche R. Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am J Respir Crit Care Med 2004;170:70-77.
3. Vandamme P, Holmes B, Vancanneyt M, Coenye T, Hoste B, Coopman R, Revets H, Lauwers S, Gillis M, Kersters K, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol 1997;47:1188-1200.
4. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002;8:181-187.
5. LiPuma JJ, Spilker T, Gill LH, Campbell PW 3rd, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 2001;164:92-96.
6. Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LT, Davidson AG, Wilcox PG, Nakielna B, Speert DP. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis 2001;33:1469-1475.
7. De Soyza A, McDowell A, Archer L, Dark JH, Elborn SJ, Mahenthiralingam E, Gould K, Corris PA. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001;358:1780-1781.
8. Aris RM, Routh JC, LiPuma JJ, Heath DG, Gilligan PH. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex: survival linked to genomovar type. Am J Respir Crit Care Med 2001;164:2102-2106.
9. Ernst RK, Yi EC, Guo L, Lim KB, Burns JL, Hackett M, Miller SI. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 1999;286:1561-1565.
10. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 2002;3:354-359.
11. O'Neill LA. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr Top Microbiol Immunol 2002;270:47-61.